Search
Search Results
-
The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation
BackgroundTardive dyskinesia (TD), a movement disorder in which patients experience abnormal involuntary movements, can have profound negative...
-
Tardive Dyskinesia with Antipsychotic Medication in Children and Adolescents: A Systematic Literature Review
BackgroundTardive dyskinesia (TD) is a persisting, and potentially irreversible, movement disorder associated with treatment with dopamine receptor...
-
Impact of tardive dyskinesia on patients and caregivers: a survey of caregivers in the United States
BackgroundTardive dyskinesia (TD) has a multidimensional impact on patients with TD and, as importantly, their caregivers. An online survey was...
-
RETRACTED ARTICLE: Pallidal deep brain stimulation for tardive dystonia: meta-analysis of clinical outcomes
IntroductionTardive dystonia (TD) is a disabling complication of pharmacological therapy with dopaminergic receptor antagonists, usually resistant to...
-
Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease
IntroductionDeutetrabenazine is a vesicular monoamine transporter 2 inhibitor used to treat tardive dyskinesia (TD) and chorea associated with...
-
“Evaluating and Managing Tardive Dyskinesia in the Older Adult”
Purpose of ReviewTardive dyskinesia is an iatrogenic hyperkinetic movement disorder caused by chronic exposure to antidopaminergic agents. The older...
-
Impact of possible tardive dyskinesia on physical wellness and social functioning: results from the real-world RE-KINECT study
BackgroundTardive dyskinesia (TD) is a persistent and potentially disabling movement disorder associated with antipsychotic use. Data from RE-KINECT,...
-
Long-term effects of pallidal deep brain stimulation in tardive dystonia: a follow-up of 5–14 years
IntroductionPallidal DBS is an established treatment for severe isolated dystonia. However, its use in disabling and treatment-refractory tardive...
-
Genome wide study of tardive dyskinesia in schizophrenia
Tardive dyskinesia (TD) is a severe condition characterized by repetitive involuntary movement of orofacial regions and extremities. Patients treated...
-
Efficacy and safety of Transcranial Direct Current Stimulation (tDCS) on cognitive function in chronic schizophrenia with Tardive Dyskinesia (TD): a randomized, double-blind, sham-controlled, clinical trial
ObjectivePrevious studies have shown that transcranial direct current stimulation(tDCS) led to an improvement of cognitive function in patients with...
-
Patient perspective of tardive dyskinesia: results from a social media listening study
BackgroundTardive dyskinesia (TD) is a persistent and potentially disabling movement disorder associated with prolonged exposure to dopamine receptor...
-
-
Tardive dystonia improved with discontinuation of trazodone in an elderly schizophrenia patient: a case report
BackgroundTardive dystonia associated with antidepressant use is rare and often under-recognized. We had an experience with trazodone, which is used...
-
Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia
BackgroundThe relative benefits and risks of long-term maintenance treatment with antipsychotics have not been well studied in patients with bipolar...
-
Tardive Dyskinesia: Treatment Update
Purpose of ReviewTardive dyskinesia (TD) is caused by exposure to medications with dopamine antagonism, mainly antipsychotics. It often distresses...
-
Significance of an altered lncRNA landscape in schizophrenia and cognition: clues from a case–control association study
Genetic etiology of schizophrenia is poorly understood despite large genome-wide association data. Long non-coding RNAs (lncRNAs) with a probable...
-
Tardive Reactivation of Progressive Multiple Sclerosis During Treatment with Biotin
Multiple sclerosis (MS) is a common autoimmune disease of the central nervous system, causing neurological disability in young adults. A growing...
-
An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders
Drug-induced movement disorders (DIMDs) are associated with use of dopamine receptor blocking agents (DRBAs), including antipsychotics. The most...
